vs

Side-by-side financial comparison of HUBSPOT INC (HUBS) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.

Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $846.7M, roughly 1.7× HUBSPOT INC). HUBSPOT INC runs the higher net margin — 6.4% vs 3.6%, a 2.8% gap on every dollar of revenue. On growth, HUBSPOT INC posted the faster year-over-year revenue change (20.4% vs 12.2%). HUBSPOT INC produced more free cash flow last quarter ($234.0M vs $130.2M). Over the past eight quarters, HUBSPOT INC's revenue compounded faster (17.1% CAGR vs 13.0%).

HubSpot, Inc. is a US-based developer and marketer of software products for marketing, sales, and customer service. HubSpot was founded by Brian Halligan and Dharmesh Shah in 2006. The global headquarters is in Cambridge, MA.

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

HUBS vs OPCH — Head-to-Head

Bigger by revenue
OPCH
OPCH
1.7× larger
OPCH
$1.4B
$846.7M
HUBS
Growing faster (revenue YoY)
HUBS
HUBS
+8.2% gap
HUBS
20.4%
12.2%
OPCH
Higher net margin
HUBS
HUBS
2.8% more per $
HUBS
6.4%
3.6%
OPCH
More free cash flow
HUBS
HUBS
$103.7M more FCF
HUBS
$234.0M
$130.2M
OPCH
Faster 2-yr revenue CAGR
HUBS
HUBS
Annualised
HUBS
17.1%
13.0%
OPCH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HUBS
HUBS
OPCH
OPCH
Revenue
$846.7M
$1.4B
Net Profit
$54.4M
$51.8M
Gross Margin
83.7%
19.0%
Operating Margin
5.7%
5.9%
Net Margin
6.4%
3.6%
Revenue YoY
20.4%
12.2%
Net Profit YoY
992.2%
-3.8%
EPS (diluted)
$1.03
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HUBS
HUBS
OPCH
OPCH
Q4 25
$846.7M
Q3 25
$809.5M
$1.4B
Q2 25
$760.9M
$1.4B
Q1 25
$714.1M
$1.3B
Q4 24
$703.2M
$1.3B
Q3 24
$669.7M
$1.3B
Q2 24
$637.2M
$1.2B
Q1 24
$617.4M
$1.1B
Net Profit
HUBS
HUBS
OPCH
OPCH
Q4 25
$54.4M
Q3 25
$16.5M
$51.8M
Q2 25
$-3.3M
$50.5M
Q1 25
$-21.8M
$46.7M
Q4 24
$5.0M
$60.1M
Q3 24
$8.1M
$53.9M
Q2 24
$-14.4M
$53.0M
Q1 24
$5.9M
$44.8M
Gross Margin
HUBS
HUBS
OPCH
OPCH
Q4 25
83.7%
Q3 25
83.5%
19.0%
Q2 25
83.9%
19.0%
Q1 25
83.9%
19.7%
Q4 24
85.3%
21.3%
Q3 24
85.2%
20.1%
Q2 24
85.0%
20.3%
Q1 24
84.6%
20.8%
Operating Margin
HUBS
HUBS
OPCH
OPCH
Q4 25
5.7%
Q3 25
1.4%
5.9%
Q2 25
-3.2%
5.8%
Q1 25
-3.8%
5.9%
Q4 24
-1.5%
6.9%
Q3 24
-1.4%
6.7%
Q2 24
-3.8%
6.6%
Q1 24
-3.8%
6.0%
Net Margin
HUBS
HUBS
OPCH
OPCH
Q4 25
6.4%
Q3 25
2.0%
3.6%
Q2 25
-0.4%
3.6%
Q1 25
-3.1%
3.5%
Q4 24
0.7%
4.8%
Q3 24
1.2%
4.2%
Q2 24
-2.3%
4.3%
Q1 24
1.0%
3.9%
EPS (diluted)
HUBS
HUBS
OPCH
OPCH
Q4 25
$1.03
Q3 25
$0.31
$0.32
Q2 25
$-0.06
$0.31
Q1 25
$-0.42
$0.28
Q4 24
$0.09
$0.36
Q3 24
$0.16
$0.31
Q2 24
$-0.28
$0.30
Q1 24
$0.12
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HUBS
HUBS
OPCH
OPCH
Cash + ST InvestmentsLiquidity on hand
$882.2M
$309.8M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$2.1B
$1.4B
Total Assets
$3.9B
$3.5B
Debt / EquityLower = less leverage
0.86×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HUBS
HUBS
OPCH
OPCH
Q4 25
$882.2M
Q3 25
$614.4M
$309.8M
Q2 25
$601.2M
$198.8M
Q1 25
$625.0M
$171.4M
Q4 24
$512.7M
$412.6M
Q3 24
$410.1M
$483.0M
Q2 24
$797.9M
$376.9M
Q1 24
$447.8M
$219.5M
Total Debt
HUBS
HUBS
OPCH
OPCH
Q4 25
Q3 25
$1.2B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Q1 24
$1.1B
Stockholders' Equity
HUBS
HUBS
OPCH
OPCH
Q4 25
$2.1B
Q3 25
$1.9B
$1.4B
Q2 25
$2.1B
$1.4B
Q1 25
$2.0B
$1.4B
Q4 24
$1.9B
$1.4B
Q3 24
$1.8B
$1.4B
Q2 24
$1.6B
$1.4B
Q1 24
$1.4B
$1.4B
Total Assets
HUBS
HUBS
OPCH
OPCH
Q4 25
$3.9B
Q3 25
$3.5B
$3.5B
Q2 25
$3.7B
$3.4B
Q1 25
$3.9B
$3.3B
Q4 24
$3.8B
$3.4B
Q3 24
$3.6B
$3.4B
Q2 24
$3.4B
$3.3B
Q1 24
$3.2B
$3.2B
Debt / Equity
HUBS
HUBS
OPCH
OPCH
Q4 25
Q3 25
0.86×
Q2 25
0.82×
Q1 25
0.82×
Q4 24
0.79×
Q3 24
0.78×
Q2 24
0.79×
Q1 24
0.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HUBS
HUBS
OPCH
OPCH
Operating Cash FlowLast quarter
$247.4M
$139.4M
Free Cash FlowOCF − Capex
$234.0M
$130.2M
FCF MarginFCF / Revenue
27.6%
9.1%
Capex IntensityCapex / Revenue
1.6%
0.6%
Cash ConversionOCF / Net Profit
4.55×
2.69×
TTM Free Cash FlowTrailing 4 quarters
$707.6M
$220.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HUBS
HUBS
OPCH
OPCH
Q4 25
$247.4M
Q3 25
$187.4M
$139.4M
Q2 25
$164.4M
$90.3M
Q1 25
$161.6M
$-7.2M
Q4 24
$194.1M
$36.1M
Q3 24
$159.5M
$160.4M
Q2 24
$117.8M
$195.7M
Q1 24
$127.1M
$-68.8M
Free Cash Flow
HUBS
HUBS
OPCH
OPCH
Q4 25
$234.0M
Q3 25
$177.0M
$130.2M
Q2 25
$148.3M
$81.2M
Q1 25
$148.2M
$-16.6M
Q4 24
$181.4M
$25.8M
Q3 24
$148.4M
$150.7M
Q2 24
$109.6M
$185.9M
Q1 24
$121.2M
$-74.6M
FCF Margin
HUBS
HUBS
OPCH
OPCH
Q4 25
27.6%
Q3 25
21.9%
9.1%
Q2 25
19.5%
5.7%
Q1 25
20.8%
-1.2%
Q4 24
25.8%
2.0%
Q3 24
22.2%
11.8%
Q2 24
17.2%
15.1%
Q1 24
19.6%
-6.5%
Capex Intensity
HUBS
HUBS
OPCH
OPCH
Q4 25
1.6%
Q3 25
1.3%
0.6%
Q2 25
2.1%
0.6%
Q1 25
1.9%
0.7%
Q4 24
1.8%
0.8%
Q3 24
1.7%
0.8%
Q2 24
1.3%
0.8%
Q1 24
1.0%
0.5%
Cash Conversion
HUBS
HUBS
OPCH
OPCH
Q4 25
4.55×
Q3 25
11.33×
2.69×
Q2 25
1.79×
Q1 25
-0.15×
Q4 24
38.96×
0.60×
Q3 24
19.59×
2.98×
Q2 24
3.69×
Q1 24
21.42×
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HUBS
HUBS

Subscription And Circulation$829.0M98%
Services$17.8M2%

OPCH
OPCH

Commercial Customer$1.3B87%
Government Customer$172.8M12%
Patient Customer$10.1M1%
Corporate Joint Venture$1.9M0%

Related Comparisons